FDA

A Sea-Change is Coming in How Laboratory-Developed Tests are Regulated – Is your Lab Ready?

By Inga Rose & and Aaron Schlum – On May 6, FDA published a final rule that will change the way laboratory-developed tests are regulated. The rule phases out the agency’s general policy of “enforcement discretion” and mandates that, across five stages within the next four years, LDTs will be beholden to the same regulatory requirements as in vitro diagnostics.

Read More

FDA Promotes Clinical Trial Innovation

By Hilary Marston MD MPH & Kevin Bugin PhD – Breakthroughs in science and technology are advancing innovation in more areas of medicine, providing novel treatment options for patients. The scientific community has a deepening understanding of disease and human biology, and of the enormous potential afforded through new technologies.



Realizing the Promise of Real-World Evidence

By Robert Califf – What we now call real-world data (RWD) have been used for years in medical product development to inform study design and endpoint selection, identify potential participants and trial sites, and assess safety in the post-marketing setting.





Health IT Product News Report – February 2022

The health IT industry is driven by growing demand for improved patient safety and patient care as well as increase in government initiatives to promote and adopt health IT. It is estimated to reach $149,178 million by 2025. Here is product news that is making these number real.